Lytton, Laurence W. 13D and 13G filings for Gyre Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 1:18 pm Unchanged | 2023-12-31 | 13G | Gyre Therapeutics, Inc. GYRE | Lytton, Laurence W. | 0 0.000% | 0 (Unchanged) | Filing |